Brief: Mirum’S Livmarli Now FDA Approved In Tablet Formulation
14/04/2025 14:27
April 14 (Reuters) - Mirum Pharmaceuticals Inc MIRM.O: MIRUM’S LIVMARLI NOW FDA APPROVED IN TABLET FORMULATION MIRUM PHARMACEUTICALS INC - LIVMARLI TABLETS TO BE AVAILABLE IN JUNE Source text: ID:nBw3JGQb3a Further company coverage: MIRM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mirum Pharmaceuticals
See all newsMirum Pharmaceuticals Q3 net product sales surge, outlook raised
Brief: Mirum Pharmaceuticals Announces Positive Results From Cohort 2 Of The Pivotal Progress Study Of Atebrioz™ (Zilurgisertib) In Pediatric Patients Aged 6 To <12 Years With Fibrodysplasia Ossificans Progressiva
Mirum climbs on positive late-stage trial results for liver disease drug
US STOCKS ON THE MOVE-Mirum Pharmaceuticals, Meta, Boeing
U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, SpaceX